Novo Nordisk rejects Baxter patent claim over Novoeight
May 20, 2015 at 10:52 AM EDT
COPENHAGEN, May 20 (Reuters) - Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that it had infringed patents on drugs to treat the bleeding disorder haemophilia, the Danish company said on Wednesday.
